Screener
Balchem BCPC D&A
D&A at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Balchem in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The source filing: Balchem’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:33 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000009326-26-000018
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Cash flows from operating activities: | ||
| Net earnings | $40,285 | $37,053 |
| Adjustments to reconcile net earnings to net cash provided by operating activities: | ||
| Depreciation and amortization | 12,491 | 11,014 |
| Stock compensation expense | 5,356 | 3,810 |
| Deferred income taxes | (187) | (115) |
| Provision for (recovery of) credit losses | 289 | (79) |
| Unrealized loss on foreign currency transactions and deferred compensation | 717 | 24 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Balchem's D&A?
- Balchem (BCPC) reported D&A of $12.49M in Q1 2026.
- How has Balchem's D&A changed year-over-year?
- Balchem's D&A increased by 13.4% year-over-year, from $11.01M to $12.49M.
- What is the long-term trend for Balchem's D&A?
- Over 4 years (2021 to 2025), Balchem's D&A has grown at a -1.7% compound annual growth rate (CAGR), from $48.88M to $45.69M.
- What does D&A mean?
- Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.
Ask your AI about Balchem's d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude